Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF Mutation: Which One First? D. Moreno-Ramírez, A. Fernández-Orland, L. Ferrándiz

Malignant Melanoma–a Genetic Overview S. Bloethner, D. Scherer, M. Drechsel, K. Hemminki, R. Kumar

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management S.J.E. Hwang, R. Anforth, G. Carlos, P. Fernandez-Peñas